Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
暂无分享，去创建一个
Rosalyn W. Sayaman | L. Esserman | N. Hylton | Minetta C. Liu | D. Yee | C. Yau | W. Symmans | H. Rugo | C. Isaacs | A. DeMichele | H. Sethi | D. Wolf | M. Rabinowitz | R. Nanda | K. Albain | D. Tripathy | J. Perlmutter | A. Chien | G. Hirst | Wen Li | A. Forero-Torres | A. Aleshin | E. Kalashnikova | M. Magbanua | A. Delson | S. Asare | D. Renner | Angel Rodriguez | L. J. van ’t Veer | L. Brown Swigart | Ziad Ahmed | A. J. Chien | Amy L. Delson | Amy L Delson